Mark Kinarney

Senior Director, Investor Relations, Lantheus Holdings, Inc.

After graduate school, Mark spent nine years in equity research at Merrill Lynch, Morgan Stanley and UBS.

After several years away, Mark returned to the sell side to work in corporate access at Credit Suisse for four years. From 2016-2018, Mark worked on the Investor Relations team at Foster City-based biotech, Gilead Sciences. In late 2018, Mark joined Lantheus where he serves as Senior Director and Head of Investor Relations.